Bulletin
Investor Alert

Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

After Hours

/zigman2/quotes/207821052/composite

$

131.50

Change

-0.03 -0.02%

Volume

Volume 13,095

Oct 22, 2021, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/207821052/composite

Previous close

$ 134.21

$ 131.53

Change

-2.68 -2.00%

Day low

Day high

$129.50

$135.14

Open
Open: 133.64

52 week low

52 week high

$23.49

$202.73

Open

Market cap

$9.67B

Average volume

805,875

P/E ratio

N/A

Rev. per Employee

$185,878

EPS

-2.86

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ntla

MarketWatch News on NTLA

  1. Prime Is the Newest Gene Editing, and It's Getting Better

    7:11 p.m. Oct. 20, 2021

    - Barron's Online

  2. This Fund Is Winning Big by Betting on Stocks That Help Humanity

    7:37 a.m. Sept. 27, 2021

    - Barron's Online

  3. Intellia Therapeutics started at buy with $173 stock price target at Stifel Nicolaus

    7:59 a.m. Sept. 24, 2021

    - Tomi Kilgore

  4. Intellia Therapeutics stock price target raised to $190 from $90 at Evercore ISI

    5:58 a.m. Aug. 6, 2021

    - Tomi Kilgore

  5. The Best and Worst Biopharma Stock Performers So Far in 2021

    11:32 a.m. June 30, 2021

    - Barron's Online

  6. Intellia Therapeutics price target raised to $168 from $106 at Raymond James, stock rated outperform

    7:37 a.m. June 29, 2021

    - Tonya Garcia

  7. Intellia Therapeutics price target doubled to $160 from $80 at Truist Securities, stock maintained at buy

    11:24 a.m. June 28, 2021

    - Tonya Garcia

  8. Intellia Stock Is Rocketing Because of a Gene-Editing Breakthrough

    9:21 a.m. June 30, 2021

    - Barron's Online

  9. First In-Vivo Gene Editing Data Look Good for Intellia

    8:40 a.m. June 28, 2021

    - Barron's Online

  10. Biotech M&A Has Been Slow This Year. Why It Might Get Busier.

    8:32 a.m. May 21, 2021

    - Barron's Online

  11. Biotech stocks are a buy — especially these 18 picks

    2:02 p.m. March 13, 2021

    - Michael Brush

  12. Intellia Therapeutics price target raised to $106 from $39 at Raymond James

    8:50 a.m. Jan. 8, 2021

    - Tonya Garcia

  13. The 12 Most Overpriced Stocks in America

    8:48 a.m. Dec. 28, 2020

    - Barron's Online

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/ntla

Other News on NTLA

  1. Biotech Buyouts That Would Be Great for Investors

    7:05 a.m. Oct. 22, 2021

    - Motley Fool

  2. SESN, KDMN and RMED among pre market gainers

    8:32 a.m. Oct. 21, 2021

    - Seeking Alpha

  3. Intellia Moves Into Eye Treatments With SparingVision Deal

    4:09 p.m. Oct. 18, 2021

    - GuruFocus.com

  4. Michael Burry's Russell 2000 Short

    9:56 a.m. Oct. 18, 2021

    - GuruFocus.com

  5. 2 Gene-Editing Stocks to Have on Your Radar Right Now

    9:01 a.m. Oct. 17, 2021

    - Motley Fool

  6. 3 Top Breakout Stocks to Buy Right Now

    5:52 a.m. Oct. 15, 2021

    - Motley Fool

  7. 3 Biotech Stocks You Can Buy and Hold for the Next Decade

    7:15 a.m. Oct. 13, 2021

    - Motley Fool

  8. Intellia Therapeutics (NTLA) Investor Presentation - Slideshow

    11:44 a.m. Oct. 8, 2021

    - Seeking Alpha

  9. Intellia Therapeutics slides after insider selling

    10:56 a.m. Oct. 8, 2021

    - Seeking Alpha

  10. Ipswich Investment Management Co., Inc. Buys Salesforce. ...

    12:38 p.m. Oct. 7, 2021

    - GuruFocus.com

  11. Loading more headlines...
/news/pressrelease/company/us/ntla

Press Releases on NTLA

  1. Why Regeneron, Intellia Therapeutics On Sale

    6:43 a.m. Oct. 14, 2021

    - Baystreet.ca

  2. IWM, UTSL: Big ETF Inflows

    10:47 a.m. Sept. 28, 2021

    - MarketNewsVideo.com

  3. Intellia Shoots High on New Deal with Regeneron

    9:57 a.m. June 28, 2021

    - Baystreet.ca

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.